Hana Kopecka

964 citations

26 papers · 742 indexed · h-index 15

Molecular Biology
Organic Chemistry top 10%
Cellular and Molecular Neuroscience top 10%
Pharmacology top 10%
Oncology

Co-authors: Thomas M. Harris Constance M. Harris Kannan Rajamoorthi Alex M. Nadzan James F. Kerwin David G. Witte Nan‐Horng Lin Richard L. Elliott
Topics: Neuropeptides and Animal Physiology (11 papers)Peptidase Inhibition and Analysis (7 papers)Chemical Synthesis and Analysis (4 papers)
Cited by: Cellular and Molecular Neuroscience Pharmacology Organic Chemistry
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States United Kingdom

In The Last Decade

Hana Kopecka

24 papers receiving 708 citations

Peers

Countries citing papers authored by Hana Kopecka

Since Specialization

Citations

This map shows the geographic impact of Hana Kopecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana Kopecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana Kopecka more than expected).

Fields of papers citing papers by Hana Kopecka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hana Kopecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana Kopecka. The network helps show where Hana Kopecka may publish in the future.

Co-authorship network of co-authors of Hana Kopecka

This figure shows the co-authorship network connecting the top 25 collaborators of Hana Kopecka. A scholar is included among the top collaborators of Hana Kopecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hana Kopecka. Hana Kopecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit 2007 ·Bioorganic & Medicinal Chemistry Letters ·Bradley J. Backes,Kenton L. Longenecker,Gregory L. Hamilton,Kent D. Stewart,Chunqiu Lai,Hana Kopecka,Thomas W von Geldern,David J. Madar,Zhonghua Pei,Thomas Lübben,Bradley A. Zinker,(unknown),Stephen J. Ballaron,Michael A. Stashko,Amanda K. Mika,David W. A. Beno,Anita J. Kempf-Grote,(unknown),Hing L. Sham,James M. Trevillyan	31
2	Minor Structural Differences in Boc-CCK-4 Derivatives Dictate Affinity and Selectivity for CCK-A and CCK-B Receptors 1997 ·Journal of Medicinal Chemistry ·Kazumi Shiosaki,Chun Wel Lin,Hana Kopecka,Bruce R. Bianchi,Thomas R. Miller,Michael A. Stashko,David G. Witte	2
3	2-(Aryloxymethyl) azacyclic analogues as novel nicotinic acetylcholine receptor (nAChR) ligands 1996 ·Bioorganic & Medicinal Chemistry Letters ·Richard L. Elliott,Hana Kopecka,David Gunn,Nan‐Horng Lin,David S. Garvey,Keith B. Ryther,Mark W. Holladay,David J. Anderson,Jeffrey E. Campbell,James P. Sullivan,Michael Buckley,Karen L. Gunther,Alyssa B. O'Neill,Michael Decker,Stephen P. Arnerić	18
4	A Short, Efficient Synthesis of the Novel Cholinergic Channel Activator, ABT 418, from L-Proline 1995 ·Synthesis ·Richard L. Elliott,Hana Kopecka,Nan‐Horng Lin,Yun He,David S. Garvey	44
5	Novel Asp32-Replacement Tetrapeptide Analogs as Potent and Selective CCK-A Agonists 1994 ·Journal of Medicinal Chemistry ·Richard L. Elliott,Hana Kopecka,Michael D. Tufano,Youe‐Kong Shue,(unknown),(unknown),Bruce R. Bianchi,(unknown),David G. Witte	8
6	Tetrapeptide CCK-A Agonists: Effect of Backbone N-Methylations on in vitro and in vivo CCK Activity 1994 ·Journal of Medicinal Chemistry ·Mark W. Holladay,Hana Kopecka,Thomas R. Miller,Lisa Bednarz,Arthur L. Nikkel,Bruce R. Bianchi,David G. Witte,Kazumi Shiosaki,(unknown)	13
7	Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus 1994 ·Journal of Medicinal Chemistry ·Richard L. Elliott,Hana Kopecka,Michael J. Bennett,(unknown),R.G. Craig,Chun Wel Lin,Bruce R. Bianchi,Thomas R. Miller,David G. Witte	9
8	Double bond isosteres of the peptide bond: Synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs 1993 ·Bioorganic & Medicinal Chemistry ·Youe‐Kong Shue,Michael D. Tufano,George M. Carrera,Hana Kopecka,(unknown),Mark W. Holladay,Chun Wel Lin,David G. Witte,Thomas R. Miller,(unknown),Alex M. Nadzan	6
9	Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N.epsilon.)-amide residues 1992 ·Journal of Medicinal Chemistry ·Kazumi Shiosaki,Chun Wel Lin,Hana Kopecka,(unknown),Bruce R. Bianchi,Thomas R. Miller,(unknown),Michael A. Stashko,Alex M. Nadzan	6
10	Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-A receptor agonists 1991 ·Journal of Medicinal Chemistry ·Kazumi Shiosaki,(unknown),Hana Kopecka,Michael D. Tufano,(unknown),Thomas R. Miller,(unknown),Alex M. Nadzan	24
11	Cholecystokinin (CCK) antagonists: (R)-tryptophan-based hybrid antagonists of high affinity and selectivity for CCK-A receptors 1991 ·Journal of Medicinal Chemistry ·James F. Kerwin,Frank L. Wagenaar,Hana Kopecka,(unknown),Thomas R. Miller,David G. Witte,Michael A. Stashko,Alex M. Nadzan	21
12	Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors. 1991 ·Molecular Pharmacology ·(unknown),Kazumi Shiosaki,Ted R. Miller,David G. Witte,Benedetta Bianchi,(unknown),Hana Kopecka,(unknown),Frank L. Wagenaar,Alex M. Nadzan	27
13	Development of CCK-tetrapeptide analogs as potent and selective CCK-A receptor agonists 1990 ·Journal of Medicinal Chemistry ·Kazumi Shiosaki,(unknown),Hana Kopecka,R.G. Craig,Frank L. Wagenaar,Bruce R. Bianchi,Thomas L. Miller,David G. Witte,Alex M. Nadzan	30
14	Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists 1989 ·Journal of Medicinal Chemistry ·James F. Kerwin,Alex M. Nadzan,Hana Kopecka,Chun Wel Lin,Thomas R. Miller,David G. Witte,Stanley K. Burt	25
15	Centrally administered CCK-8 suppresses activity in mice by a “peripheral-type” CCK receptor 1989 ·Pharmacology Biochemistry and Behavior ·Donald R. Britton,(unknown),Mary Jane Cullen,James F. Kerwin,Hana Kopecka,Alex M. Nadzan	18
16	Evidence that type A CCK receptors facilitate dopamine efflux in rat brain 1988 ·European Journal of Pharmacology ·Thomas W. Vickroy,(unknown),James F. Kerwin,Hana Kopecka,Alex M. Nadzan	41
17	Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas. 1986 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),Benedetta Bianchi,D. A. Grant,Ted R. Miller,(unknown),Michael D. Tufano,Hana Kopecka,Alex M. Nadzan	21
18	ChemInform Abstract: The Role of the Chlorine Substituents in the Antibiotic Vancomycin: Preparation and Characterization of Mono‐ and Didechlorovancomycin. 1986 ·Chemischer Informationsdienst ·Constance M. Harris,(unknown),Hana Kopecka,Thomas M. Harris	1
19	The stabilization of vancomycin by peptidoglycan analogs. 1985 ·The Journal of Antibiotics ·Constance M. Harris,Hana Kopecka,Thomas M. Harris	16
20	Thermal decomposition of 10,11-methylenedioxy-3,4,12-trimethoxy-7,8,13,13a-tetrahydro-5H-isoindolo[1,2-b] [3]benzazepine methohydroxide 1975 ·Collection of Czechoslovak Chemical Communications ·(unknown),J. HOLUBEK,Hana Kopecka,J. Trojánek	0

About Hana Kopecka

Hana Kopecka is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and General Social Sciences, having authored 26 papers that have together received 742 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (11 papers), Peptidase Inhibition and Analysis (7 papers) and Chemical Synthesis and Analysis (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (196 citations), Pharmacology (169 citations) and Organic Chemistry (284 citations). Hana Kopecka has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Thomas M. Harris, Constance M. Harris, Kannan Rajamoorthi, Alex M. Nadzan, James F. Kerwin, David G. Witte, Nan‐Horng Lin, Richard L. Elliott, Yun He and Kazumi Shiosaki. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact